- Home
- SCS vs SRPT Comparison
SCS vs SRPT Comparison
Compare SCS & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCS
- SRPT
- Stock Information
- Founded
- SCS 1912
- SRPT 1980
- Country
- SCS United States
- SRPT United States
- Employees
- SCS N/A
- SRPT N/A
- Industry
- SCS Office Equipment/Supplies/Services
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- SCS Consumer Discretionary
- SRPT Health Care
- Exchange
- SCS Nasdaq
- SRPT Nasdaq
- Market Cap
- SCS 1.8B
- SRPT 1.9B
- IPO Year
- SCS 1998
- SRPT 1997
- Fundamental
- Price
- SCS $15.83
- SRPT $18.07
- Analyst Decision
- SCS
- SRPT Hold
- Analyst Count
- SCS 0
- SRPT 30
- Target Price
- SCS N/A
- SRPT $35.93
- AVG Volume (30 Days)
- SCS 1.3M
- SRPT 6.0M
- Earning Date
- SCS 12-17-2025
- SRPT 11-03-2025
- Dividend Yield
- SCS 2.54%
- SRPT N/A
- EPS Growth
- SCS N/A
- SRPT N/A
- EPS
- SCS 0.81
- SRPT N/A
- Revenue
- SCS $3,259,000,000.00
- SRPT $2,413,715,000.00
- Revenue This Year
- SCS $5.09
- SRPT $10.20
- Revenue Next Year
- SCS $2.83
- SRPT N/A
- P/E Ratio
- SCS $19.53
- SRPT N/A
- Revenue Growth
- SCS 3.92
- SRPT 47.15
- 52 Week Low
- SCS $9.32
- SRPT $10.42
- 52 Week High
- SCS $17.40
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- SCS 35.24
- SRPT 40.79
- Support Level
- SCS $15.63
- SRPT $16.90
- Resistance Level
- SCS $15.97
- SRPT $18.80
- Average True Range (ATR)
- SCS 0.27
- SRPT 1.41
- MACD
- SCS -0.06
- SRPT -0.66
- Stochastic Oscillator
- SCS 12.20
- SRPT 30.73
About SCS Steelcase Inc.
Steelcase Inc is a furniture company based in the United States. Its brands, such as Steelcase, AMQ, Coalesse, Designtex, and others, offer a portfolio of furniture and architectural products and services designed to help customers create workplaces. It markets its products and services to businesses and organizations predominantly through a network of dealers and also sells to consumers in markets around the world through web-based and retail distribution channels. The company's reportable segments include the Americas, which generates key revenue, and the International segment.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.